'Frustrated and disappointed' Steven Gerrard reacts to Rangers' failed ban appeal for Bongani Zungu, Nathan Patterson and Calvin Bassey

Steven Gerrard has backed Rangers’ statement hitting out at the suspensions imposed on five players for a breach in covid regulations.

Rangers' Nathan Patterson (L) celebrates making it 4-0 with Calvin Bassey during a Scottish Cup Third Round tie between Rangers and Cove Rangers at Ibrox Stadium, on April 04, 2021, in Glasgow, Scotland. (Photo by Alan Harvey / SNS Group)

The club appealed six-match bans handed out to first team players Nathan Patterson Bongani Zungu and Calvin Bassey, as well as loaned-out duo Brian Kinnear and Dapo Mebude.

That allowed a first-team stay of execution for the players, particularly Patterson who played two Scottish Cup ties as well as featuring against Hibs and St Johnstone in the SPFL Premiership.

Sign up to our Football newsletter

Sign up to our Football newsletter

Gerrard said: “We found the outcome out yesterday morning and obviously not too happy about it. I said I was frustarted and disappointed that all of the players are going to receive a ban – it’s not just about Nathan. They’re all as important as eachother.

“For me, I’m frustrated and disappointed they’re not available in the next four games, but it is what it is.

“We put a statement out which I back very much in terms of the club and we move forward.”

Patterson and Bassey both played off the bench in Wednesday night's dress rehearsal ahead of Sunday’s Scottish Cup quarter final against St Johnstone.

Both played off the bench in the 1-1 draw at McDiarmid Park.

Kinnear is currently on loan at Annan Athletic and Mebude at Queen of the South. South African midfielder Zungu is on loan at Rangers from SC Amiens.

Get a year of unlimited access to all The Scotsman's sport coverage without the need for a full subscription. Expert analysis of the biggest games, exclusive interviews, live blogs, transfer news and 70 per cent fewer ads on Scotsman.com - all for less than £1 a week. Subscribe to us today


Want to join the conversation? Please or to comment on this article.